Table 2.
Langerhans cell density on in vivo confocal microscopy in the central and peripheral cornea in rheumatological conditions.
Central Langerhans cell density in patients (cell/mm2) | Central Langerhans cell density in controls (cell/mm2) | Peripheral Langerhans cell density in patients (cell/mm2) | Peripheral Langerhans cell density in patients (cell/mm2) | |
---|---|---|---|---|
Systemic lupus erythematosus [45] | 43.08 ± 48.67 | 20.57 ± 21.04 | 124.78 ± 165.39 | 78.00 ± 39.51 |
∗Ankylosing spondylitis [49] | 75.50 (51.18–112.6) | 14.50 (0.00–35.10) | 131.0 (80.33–168.4) | 65.50 (46.75–88.00) |
Rheumatoid arthritis [52] | 68.15 ± 71.27 | 23.85 ± 33.81 | 126.8 ± 104.6 | 69.29 ± 33.26 |
∗Figures for ankylosing spondylitis are expressed as median with interquartile range and others as a mean with standard deviation.